# A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

> **NCT06647810** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 690517 formulation 1
- **DRUG:** BI 690517 formulation 2
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT06647810
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-13
- **Primary completion:** 2024-12-12
- **Final completion:** 2025-01-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06647810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06647810, "A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06647810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*